Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 856.00
Bid: 854.00
Ask: 862.00
Change: -4.00 (-0.47%)
Spread: 8.00 (0.937%)
Open: 860.00
High: 860.00
Low: 856.00
Prev. Close: 860.00
MAB1 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

27 Jan 2022 07:00

RNS Number : 7696Z
Mortgage Advice Bureau(Holdings)PLC
27 January 2022
 

27 January 2022

Mortgage Advice Bureau (Holdings) plc 

("MAB" or the "Group")

Trading Update 

Mortgage Advice Bureau (Holdings) plc (AIM: MAB1) today issues a trading update for the year ended 31 December 2021, ahead of publishing its final results on Tuesday, 29 March 2022.

Despite the regulatory approval of new Appointed Representative firms taking longer than in previous years, the Group increased revenue to circa £188m for the year ended 31 December 2021. This represents a 27% increase on 2020 (£148m) and a 31% increase compared to 2019 (£144m).

The increase in revenue since 2019 is driven by the combination of a 23% increase in the average number of mainstream1 advisers to 1,649 over the two-year period (2019: 1,341) and a 7% increase in revenue per mainstream adviser. At 31 December 2021, total adviser numbers had grown to 1,8852, an increase of 305 (or 19%) for the year (31 December 2020: 1,580).

As anticipated during the second half of the year, housing market activity softened when compared to H1 2021, following the tapering and ultimately the removal of the stamp duty holiday. This was however countered by a strong increase in refinancing activity. The underlying fundamentals driving levels of consumer demand for housing and mortgage products remain strong, though activity has been constrained by the currently lower level of housing stock for sale.

The Group's adjusted profit before tax for the year ended 31 December 2021 is expected to be in line with Board expectations.

1 Excludes directly authorised advisers, later life advisers, and advisers from associates in the process of being onboarded under MAB's AR arrangements

2 Includes a total of 47 advisers at 31 December 2021 who are either directly authorised or later life advisers. The directly authorised advisers are employees of a firm previously authorised under an Appointed Representative agreement with MAB until 7 December 2020. MAB continues to provide services to this firm, which is now directly authorised by the FCA. For both later life and directly authorised advisers the fees received by MAB represent the net income received by MAB as there are no commission payouts made by MAB. Also includes 64 advisers from associates, who are in the process of being onboarded under MAB's AR arrangements. These advisers will shortly become mainstream advisers. Until these 64 advisers become onboarded fully as mainstream advisers, MAB currently only recognises its share of profit after tax from these associates.

 

Current trading

The Group starts 2022 with a strong pipeline of written business and adviser recruitment, which will be enhanced by delayed adviser starts from 2021. Refinancing activity remains positive, and demand for housing continues to be very strong, with greater activity levels only constrained by the level of housing stock for sale.

Gross new mortgage lending in 2021 was driven by a very strong purchase market, with the Intermediary Mortgage Lenders Association ("IMLA") and UK Finance estimating gross new mortgage lending for 2021 at £304bn and £316bn respectively. IMLA and UK Finance's recent estimates of gross new mortgage lending for 2022 are £275bn and £281bn respectively, representing a reduction versus 2021, with higher levels of refinancing forecast.

Current trading is in line with the Board's expectations. MAB's maturing and new growth drivers put MAB in a strong position to accelerate its pace of growth.

Peter Brodnicki, CEO of MAB, commented:

"I am delighted with MAB's performance and we enter 2022 with a strong and growing pipeline of business, ARs, advisers and lead sources, and expect to have a very strong start to the year in terms of adviser numbers.

"We are delighted with the recent investments we have made which we believe will contribute strongly, along with those that have been maturing in recent years.

"MAB's strategy of not only delivering growth in advisers, but also in adviser productivity driven by further enhancements in our technology platform, lead generation initiatives and our proposition for ARs and their advisers, will drive profitability and supports our plan for accelerated growth."

 

Enquiries:

Mortgage Advice Bureau (Holdings) plc +44 (0)1332 525007

Peter Brodnicki, Chief Executive Officer

Ben Thompson, Deputy Chief Executive Officer

Lucy Tilley, Chief Financial Officer

Nominated Adviser and Broker: +44 (0)20 7260 1000

Numis Securities Limited

Stephen Westgate / Giles Rolls

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018 ("UK MAR"). 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSELFAMEESELF
Date   Source Headline
1st May 20247:00 amRNSNotification of Major Holdings
30th Apr 20242:21 pmRNSDirectors' Shareholdings and PDMR notification
25th Apr 20244:40 pmRNSNotice of Results and AGM
23rd Apr 20244:27 pmRNSGrant of Options and Total Voting Rights
23rd Apr 20247:00 amRNSBoard Changes
17th Apr 20244:57 pmRNSPDMR dealing
15th Apr 20246:09 pmRNSDirector/PDMR Shareholding
28th Mar 20244:01 pmRNSDirectors' Shareholdings and PDMR notification
19th Mar 20247:00 amRNSFinal Results for the year ended 31 December 2023
15th Mar 20247:00 amRNSDirectors' Shareholdings and PDMR notification
8th Mar 202411:41 amRNSNotification of Major Holdings
29th Feb 20243:21 pmRNSDirectors' Shareholdings and PDMR notification
23rd Feb 20243:25 pmRNSNotification of Major Holdings
19th Feb 20246:17 pmRNSNotification of Major Holdings
19th Feb 20246:15 pmRNSNotification of Major Holdings
14th Feb 20244:09 pmRNSDirectors' Shareholdings and PDMR notification
9th Feb 20247:00 amRNSNotification of Major Holdings
6th Feb 20243:15 pmRNSNotification of Major Holdings
31st Jan 20243:38 pmRNSDirectors' Shareholdings and PDMR notification
26th Jan 20247:00 amRNSNotification of Major Holdings
25th Jan 20247:00 amRNSTrading Update
15th Jan 20243:15 pmRNSDirectors' Shareholdings and PDMR notification
15th Jan 20247:00 amRNSBoard Change
12th Jan 20241:43 pmRNSBlock listing Interim Review
29th Dec 202311:03 amRNSDirectors' Shareholdings and PDMR notification
15th Dec 202310:26 amRNSDirectors' Shareholdings and PDMR notification
30th Nov 20235:57 pmRNSDirectors' Shareholdings and PDMR notification
21st Nov 202311:49 amRNSNotification of Major Holdings
14th Nov 20234:29 pmRNSDirectors' Shareholdings and PDMR notification
3rd Nov 20233:43 pmRNSDirector/PDMR Shareholding
31st Oct 20234:00 pmRNSDirectors' Shareholdings and PDMR notification
16th Oct 20235:07 pmRNSDirectors' Shareholdings and PDMR notification
12th Oct 202311:10 amRNSNotification of Major Interest in Shares
10th Oct 20231:32 pmRNSNotification of Major Interests in Shares
9th Oct 20235:55 pmRNSNotification of Major Interests in Shares
28th Sep 202312:11 pmRNSNotification of Major Holdings
26th Sep 20237:00 amRNSInterim Results
18th Sep 20232:40 pmRNSDirectors' Shareholdings and PDMR notification
31st Aug 20234:43 pmRNSDirectors' Shareholdings and PDMR notification
14th Aug 20233:24 pmRNSDirector/PDMR Shareholding
10th Aug 20237:00 amRNSStandard form for notification of major holdings
1st Aug 202311:23 amRNSDirector/PDMR Shareholding
26th Jul 20237:00 amRNSTrading Update
21st Jul 20232:59 pmRNSNotification of major holdings
18th Jul 20235:34 pmRNSDirectors' Shareholdings and PDMR notification
17th Jul 202312:43 pmRNSDirectors' Shareholdings and PDMR notification
13th Jul 20235:03 pmRNSBlock listing Interim Review
11th Jul 20237:00 amRNSDirectors' Shareholdings and PDMR notification
30th Jun 202312:08 pmRNSDirector/PDMR Shareholding
16th Jun 202311:49 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.